Home arrow Publication Series arrow LSA Pharma arrow Financial arrow Applied NeuroSolutions Inc - Financial Report
Info: Your browser does not accept cookies. If you want to put products into your cart and purchase them you need to enable cookies.

Publication Series arrow LSA Pharma arrow Financial arrow Applied NeuroSolutions Inc - Financial Report

Applied NeuroSolutions Inc - Financial Report


Price: $350.00


Executive Summary

The Applied NeuroSolutions Inc Financial Report contains the company’s contact information, details, business overview, shares information, stock performance history, price and volume figures, dividends, market related data including relative strength, valuation and revenues. The report also includes earnings and earnings per share, margin and return ratios, financial strength, growth ratios, day’s sales outstanding, day’s outstanding inventory, cash and short-term investments per share and total common shares outstanding. Finally the report includes quarterly book value per share vs. share price. Much of the information contained in the report is included in both tabular and graphic formats.

The Applied NeuroSolutions Inc Financial Report delivers the latest and the most comprehensive intelligence available on Applied NeuroSolutions Inc’s financial performance.

Table of Contents

  • Business Summary
  • Contact Information
  • Selected Financial Data
  • Company Details
  • Product Glance (Table/Graph)
  • Disease Hub Classification (Table/Graph)
  • Product Pipeline
  • Product Catalog
  • Product Details with Description, Therapeutic Indication, Drug Class, Mechanism of Action, Current Trial, Trial Details, Partnering Details etc.
  • Patent Details (if any)
  • Recent Financings
  • Trademarks
  • Deals & Alliances
  • Management Profile
  • Recent Updates

Pages: 11


Life Science Analytics, Inc. (LSA), is a biomedical data company that provides comprehensive pipeline and financial information on more than 8,000 biomedical companies worldwide. Our data and research products serve executives in the pharmaceutical, biotech, and financial industries. LSA products provide an unbiased, accurate, independent approach to company analysis, whether for partnering or investment purposes.

Life Science Analytics reports are based on the most comprehensive database of private and public biomedical companies available.

Updated daily, the database covers 8,000 companies, over 24,000 products across 17 therapeutic categories with 700 sub-categories. LSA distills and systematizes pipeline, financial, competitive product, mechanism of action, partnering, and patent information to provide it’s clients with the most comprehensive and up-to-date information available.

View other Financial Reports from LSA

Other Similar Company Reports

CompetitorDeals & AlliancesProduct Pipeline



:

 


Download Fax Order Form/ PO Form

Request free sample pages from this product















© 2008 BioMarket Group